The completion of the £2 billion buyback removes a known capital return catalyst. Monitor GSK's next capital allocation announcement for any new buyback or dividend policy. No immediate trading action warranted.
Price Chart
Executive Summary
GSK completed its £2 billion share buyback program, purchasing 123,939,156 ordinary shares since February 24, 2025. The final tranche of 1,054,653 shares was bought between June 22-26, 2026, at an average price of approximately 1,953.54 GBp per share. This is a routine capital return milestone with no new financial data or strategic changes.
Key Facts
- GSK completed its £2 billion buyback program announced on February 24, 2025.
- Since February 24, 2025, GSK purchased 123,939,156 ordinary shares for aggregate consideration of just under £2 billion.
- The final week (June 22-26, 2026) saw purchases of 1,054,653 shares at volume-weighted average prices between 1,919.89 GBp and 1,967.46 GBp.
- Following purchases, GSK holds 270,881,064 shares in treasury and has 4,045,395,364 shares in issue (excluding treasury).
- Treasury shares represent 6.70% of total voting rights.
Financial Impact
£2 billion total buyback completed; no new financial data or guidance provided.
Risk Factors
- No new buyback program announced; capital return to shareholders may pause.
- Treasury shares at 6.70% could be reissued for acquisitions or employee compensation, potentially diluting future EPS.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-006273 |
| Document: 0001654954-26-006273-index-headers.html | 0001654954-26-006273 |
| Document: 0001654954-26-006273-index.html | 0001654954-26-006273 |
| Document: 0001654954-26-006273.txt | 0001654954-26-006273 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $50.01 $50.22 | ▲ +0.42% | ▼ −0.40% | $47.03 (−5.96%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 11, 2026 21d ago | 6-K | $48.13 $50.22 | ▲ +4.34% | ▲ +4.56% | $47.03 (−2.29%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Aug 26, 2026 5w ago | 6-K | $51.43 $50.44 | ▼ −1.92% | ▼ −1.80% | $47.03 (−8.56%) |
Aug 24, 2026 5w ago | 6-K | $51.78 $50.25 | ▼ −2.95% | ▼ −3.42% | $47.03 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access